📢 Generic Entresto is now available at Cost Plus Drugs ❗️
Sacubitril/Valsartan is now on https://t.co/HixgZoTxWB. A big step forward for those managing chronic heart failure.
Available in:
💊 24mg/26mg 30 tablets - $33.75 - https://t.co/TN4CzXDlyN
💊 49mg/51mg 30 tablets - $33.75 - https://t.co/PFy11OjWY2
💊 97mg/103mg 30 tablets - $33.75 - https://t.co/DXgs7wWMA1
➡️ No membership fees. No insurance needed. Just transparent pricing! Sign up today at https://t.co/Xk3eIxk7KS
⭐️ Thank you to Ascend Laboratories for making this possible!
I’ve seen this map several times in the past few days, and I admit it is hard to believe that it is real. People are living longer and with more complicated illness. Hard to say if rising employment in healthcare is sustainable or even good. It is what it is.
Getting really specific with my medical practice, this feels like a family medicine clinic day where I end up spending a lot of my time in the “things I do” section returning faxes, doing prior authorization requests, filling out return to work forms etc.
32/ The math's a little complicated, so we asked the actuaries at Milliman what would happen if ACOs could improve RA by 1% in 2025 (scenario 1)
Over 5 years,
MSSP payouts would go up by $2B (10%)
MA expenditures would decrease by $11B (0.2%)
Maybe ACOs should have more tools!
32/ The math's a little complicated, so we asked the actuaries at Milliman what would happen if ACOs could improve RA by 1% in 2025 (scenario 1)
Over 5 years,
MSSP payouts would go up by $2B (10%)
MA expenditures would decrease by $11B (0.2%)
Maybe ACOs should have more tools!
An unusual group of ideological allies — Obama HHS secretary Kathleen Sebelius, Trump HHS secretary Alex Azar, Paragon’s @brian_blase, Brookings’ @LorenAdler, etc — all agree: Medicare should start paying the same rate for the same service.